Barry, OppHub America Desk · · Source: prnewswire-all
$REPL Securities Fraud Lawsuit: Investors Can Lead Class Action
* Investors who lost money in Replimune Group ($REPL+WL) between October 20, 2025, and April 10, 2026, have an opportunity to lead the securities fraud class action, with a lead plaintiff deadline of October 5, 2026. * Related actions are also noted for Alibaba Group Holding Limited ($BABA+WL) and Primoris Services Corporation ($PRIM+WL) shareholders, indicating a pattern of similar legal opportunities being publicized by the same law firm.
Based on reporting from prnewswire-all.
Investors who lost money in Replimune Group (REPL) between October 20, 2025, and April 10, 2026, have until October 5, 2026, to step forward and potentially lead a securities fraud class action lawsuit. The suit alleges the company made misleading statements about its business prospects and failed to disclose material adverse facts regarding its BLA submission.
Market context for this story
As of: After HoursLoading quotes…
Informational only — not investment advice. Full markets →
$REPLReplimune Group, Inc
TradingView
Live chart & market data via TradingView · OppHub classroom · Delayed or exchange real-time per TradingView data agreements · Not investment advice
Educational TradingView chart — search any symbol in the widget. Confirm on /markets/REPL and related $PRIM, $BABA. Not investment advice.
Related markets
Shares a vertical MP4 loop to your phone's camera roll or app share sheet (Instagram, TikTok, Facebook Reels).
Replimune Group, Inc. ($REPL+WL) shareholders who incurred losses between October 20, 2025, and April 10, 2026, are being presented with an opportunity to lead a securities fraud class action lawsuit. The action, initiated by the Law Offices of Frank R. Cruz, alleges that the company and its representatives made materially false or misleading statements and failed to disclose critical information concerning its business operations and prospects.
Specifically, the complaint asserts that defendants did not disclose that concerns previously raised by the FDA regarding the BLA submission were not addressed. It further alleges that the company submitted data from an early, unplanned analysis of RP1-104, which involved only 40 patients, representing 10% of the planned 400-patient enrollment. The lawsuit claims that this, along with deficiencies in RPL-001-16 and RP1-104, could lead to the FDA rejecting the BLA, rendering prior positive statements about the company's outlook misleading.
### Money Play * Investors who lost money in Replimune Group ($REPL+WL) between October 20, 2025, and April 10, 2026, have an opportunity to lead the securities fraud class action, with a lead plaintiff deadline of October 5, 2026.
## Catalyst Analysis: Securities Fraud Allegations The primary driver for this alert is the opportunity for investors to lead a securities fraud class action lawsuit against Replimune Group. The alleged fraud centers on misleading statements and omissions concerning the company's interactions with the FDA and the data submitted for its BLA, potentially impacting investor confidence and stock valuation.
## Technical Analysis & Key Risk Watch
As this is a legal and regulatory development, traditional technical analysis levels are secondary. Key risks for investors include the outcome of the class action proceedings and any further disclosures or regulatory actions related to Replimune's BLA submission. The lead plaintiff deadline is October 5, 2026.
## Impact on Replimune Group ($REPL+WL) This development directly impacts Replimune Group by initiating a class action lawsuit that could lead to significant legal costs and reputational damage if allegations are proven. The timeframe of the alleged misconduct, October 20, 2025, to April 10, 2026, highlights a period where the company's disclosures are under scrutiny.
Read the full story
Original reporting and related coverage — attribution links only, not paid recommendations.
Trade this story
Robinhood
Webull
Tradier
IBKR
Chart this story
TradingView
Broker and exchange buttons use invite / refer-a-friend links (rewards may be capped). Charting links (TradingView) are partner offers that may pay OppHub America a commission at no extra cost to you.
OppSHOP
Full OppSHOP →As an Amazon Associate, OppHub America earns from qualifying purchases. Shopping here helps keep the site free — at no extra cost to you. Disclosure
OppSHOP
Related to this story
* Investors who lost money in Replimune Group ($REPL) between October 20
Shop related →
Investing books
Read the classics
Shop this pick →
Personal finance books
Run the household books
Shop this pick →
Trading notebooks
Write the thesis first
Shop this pick →
Monitor for charts
See every pane
Shop this pick →
Story playbook
A pre-built map of what to watch — stocks, ETFs, and educational next steps. Not personalized advice.
Snapshot date: August 25, 2026 at 7:26 PM ET
This playbook was built when the story published and is not live-updated. Prices, news, and risk can change after this date — treat it as a starting map, not a current trade ticket.
Story → money map
legal risk and shareholder lawsuits
A company called Replimune is being sued by unhappy investors who claim management misled them about drug application data. Investors who lost money can join or lead a lawsuit to try and recover funds.
What changed
A shareholder class action lawsuit was announced against Replimune Group regarding undisclosed regulatory concerns and trial data deficiencies.
Who wins / who loses
Plaintiff law firms and affected shareholders seeking recovery win attention, while current equity holders bear the brunt of legal uncertainty and reputational damage.
Time horizon
Think in terms of the next few months.
Confidence & best fit
low confidence · Long-term investor
Low confidence → prefer ETFs and “Watch,” not rushing into one stock.
Safer theme exposure (ETFs)
Baskets that own the theme without betting on one company.
Single stocks (higher risk)
Primary = closest to the story · Peers = same industry · Second-order = knock-on effects · Avoid = looks related but may be a trap
Primary
- $REPLStay away — for now
This is the main company facing a lawsuit from investors who lost money.
View $REPL chart → · End-of-day delayed data
Peer
- $BABAWatch — track, don’t rush
Another large company highlighted by the same law firm for shareholder legal actions.
View $BABA chart → · End-of-day delayed data
Second-order
- $PRIMWatch — track, don’t rush
A construction and engineering firm also appearing in the law firm's recent announcements.
View $PRIM chart → · End-of-day delayed data
Options (education only)
No strikes or expiries — a framework for how traders might express the view. Options can expire worthless.
Beginners should skip options completely here due to unpredictable legal and regulatory outcomes.
See options-friendly brokers →Income / OppHub America angle
Not a trade tip — ways to use the insight outside the market.
- Affected shareholders can file paperwork to become lead plaintiff in the class action lawsuit before the October 5, 2026 deadline.
What would break this thesis
- Dismissal of the lawsuit by the court or a rapid, favorable resolution for the company.
What to do next on OppHub America
Saved playbooks stay on this device for now.
Important
Not financial advice. OppHub America playbooks are educational market maps only — not recommendations to buy, sell, or hold any security. Markets move fast; information can be wrong or outdated. Trade and invest at your own risk. Do your own research or consult a licensed advisor.
Based on reporting from prnewswire-all.
Informational and educational only — not investment, financial, or legal advice. Disclosure
Shares a vertical MP4 loop to your phone's camera roll or app share sheet (Instagram, TikTok, Facebook Reels).